Clinical Trial Update: Atezolizumab and Stereotactic Body Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial update evaluates atezolizumab in combination with stereotactic body radiation therapy for Stage I non-small cell lung cancer. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Megan Daly, MD | Conditions: Stage I Non-Small Cell Lung Cancer | Phase 1 | Status: COMPLETED